JP2002513813A - ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法 - Google Patents

ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法

Info

Publication number
JP2002513813A
JP2002513813A JP2000547238A JP2000547238A JP2002513813A JP 2002513813 A JP2002513813 A JP 2002513813A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2002513813 A JP2002513813 A JP 2002513813A
Authority
JP
Japan
Prior art keywords
seq
protein
hpv
preparation
helicase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000547238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513813A5 (cg-RX-API-DMAC7.html
Inventor
アレックス ペレティエール
クリス エム ファーネット
Original Assignee
ベーリンガー インゲルハイム (カナダ) リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム (カナダ) リミテッド filed Critical ベーリンガー インゲルハイム (カナダ) リミテッド
Publication of JP2002513813A publication Critical patent/JP2002513813A/ja
Publication of JP2002513813A5 publication Critical patent/JP2002513813A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2000547238A 1998-05-01 1999-04-28 ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法 Pending JP2002513813A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
US60/083,942 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (2)

Publication Number Publication Date
JP2002513813A true JP2002513813A (ja) 2002-05-14
JP2002513813A5 JP2002513813A5 (cg-RX-API-DMAC7.html) 2006-06-22

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000547238A Pending JP2002513813A (ja) 1998-05-01 1999-04-28 ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法

Country Status (9)

Country Link
US (1) US6306580B1 (cg-RX-API-DMAC7.html)
EP (1) EP1073750A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002513813A (cg-RX-API-DMAC7.html)
AU (1) AU767903B2 (cg-RX-API-DMAC7.html)
CA (1) CA2326402A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0101396A3 (cg-RX-API-DMAC7.html)
IL (1) IL139270A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ508519A (cg-RX-API-DMAC7.html)
WO (1) WO1999057283A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140524A0 (en) * 1998-07-21 2002-02-10 Boehringer Ingelheim Ca Ltd Regions of papilloma virus e1 helicase involved in e1 oligomerization
HUP0201512A3 (en) 1999-06-17 2010-01-28 Boehringer Ingelheim Ca Ltd New atpase assay
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
WO2003068940A2 (en) * 2002-02-14 2003-08-21 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) * 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Also Published As

Publication number Publication date
CA2326402A1 (en) 1999-11-11
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
AU3592399A (en) 1999-11-23
AU767903B2 (en) 2003-11-27
US6306580B1 (en) 2001-10-23
WO1999057283A1 (en) 1999-11-11
IL139270A0 (en) 2001-11-25
NZ508519A (en) 2003-12-19
HUP0101396A3 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
Hughes et al. E1 protein of human papillomavirus is a DNA helicase/ATPase
Bierle et al. Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1
Dixon et al. The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity
Black et al. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R
PL184022B1 (pl) Izolowany kwas nukleinowy kodujący białka ludzkiego wirusa brodawczaków typu 18, wektor obejmujący ten kwas nukleinowy oraz sposób wyrażania białka ludzkiego wirusa brodawczaków typu 18 w komórce gospodarza przy użyciu tego wektora
WO2002070739A2 (en) Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
US6306580B1 (en) Preparation of human papillomavirus E1 having helicase activity and method therefor
Lu et al. Identification of a novel shrimp protein phosphatase and its association with latencey‐related ORF427 of white spot syndrome virus
US5821048A (en) Methods, kits, and compositions for diagnosing papillomavirus infection
US6300067B1 (en) TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
Castellino et al. trans-Dominant and non-trans-dominant mutant simian virus 40 large T antigens show distinct responses to ATP
US6518014B1 (en) Hepadnavirus cores
US6916622B2 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA00010584A (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
Schildgen et al. Temperature-sensitive origin-binding protein as a tool for investigations of herpes simplex virus activities in vivo
US9783584B2 (en) Methods and compositions for expressing functional class XIV myosin
AU2004200590A1 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
JP2002516096A (ja) 転写調節に使用するための、CREB結合タンパク質および関連するp300由来のポリペプチド
Ebrahimi et al. Genetic polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta1 (GSTT1) and bronchial asthma susceptibility in Ukrainian population
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
Larson et al. Functional Characterization of a Purified, Recombinant NF-κB/IκB Complex
Taylor The role of DNA damage proteins and signaling pathways in the regulatory functions of the Human Papillomavirus 16 E2 protein
JP2004173691A (ja) 変異型エストロゲンレセプターαおよびその遺伝子
WO2001097847A1 (en) Icp27-binding polynucleotides
KR19990086165A (ko) Cdk4 의 저해제인 p16의 카복시말단이 절단된 결손형cδp16 단백질, 그의 유전자

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060428

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090216

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090806